自身免疫性房颤:Kir3.4自身抗体介导的房颤新机制
研究探索无明确诱因房颤是否由针对心脏离子通道的自身抗体引起。通过肽微阵列筛查发现房颤患者存在Kir3.4自身抗体,功能实验表明该抗体缩短心房动作电位并增强IKACh,小鼠免疫模型证实其降低心房有效不应期并使房颤易感性增加2.8倍。
要点
- 无明确诱因房颤患者中存在针对Kir3.4的自身抗体反应。
- 抗Kir3.4 IgG可缩短人心房心肌细胞动作电位并增强 constitutive IKACh。
- Kir3.4免疫小鼠心房有效不应期显著缩短,房颤易感性增加2.8倍。
核心结论
- 首次报告房颤的自身免疫发病机制,直接证据支持Kir3.4自身抗体介导房颤。
研究设计与样本
- 病例对照研究: unexplained AF患者(n=37既往房颤;n=14随访中新发房颤)与年龄性别匹配对照(n=37)比较。
- 采用肽微阵列筛查自身抗体,patch clamp技术进行体外电生理测试,并建立小鼠免疫实验模型。
主要发现
- 房颤患者中检测到针对Kir3.4蛋白的常见自身抗体反应,甚至在临床显性房颤发生前即可检出。
- Kir3.4蛋白形成异四聚体,构成心脏乙酰胆碱激活的内向整流K+电流IKACh的基础。
- 从房颤患者纯化的抗Kir3.4 IgG在人心房诱导多能干细胞来源心肌细胞中缩短动作电位并增强 constitutive IKACh。
- Kir3.4免疫小鼠的电生理检查显示Kir3.4自身抗体显著降低心房有效不应期,并使房颤易感性增加2.8倍。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Atrial fibrillation (AF) is by far the most common cardiac arrhythmia. In about 3% of individuals, AF develops as a primary disorder without any identifiable trigger (idiopathic or historically termed lone AF). In line with the emerging field of autoantibody-related cardiac arrhythmias, the objective of this study was to explore whether autoantibodies targeting cardiac ion channels can underlie unexplained AF. METHODS: Peptide microarray was used to screen patient samples for autoantibodies. We compared patients with unexplained AF (n=37 pre-existent AF; n=14 incident AF on follow-up) to age- and sex-matched controls (n=37). Electrophysiological properties of the identified autoantibody were then tested in vitro with the patch clamp technique and in vivo with an experimental mouse model of immunization. RESULTS: A common autoantibody response against Kir3.4 protein was detected in patients with AF and even before the development of clinically apparent AF. Kir3.4 protein forms a heterotetramer that underlies the cardiac acetylcholine-activated inwardly rectifying K+ current, IKACh. Functional studies on human induced pluripotent stem cell-derived atrial cardiomyocytes showed that anti-Kir3.4 IgG purified from patients with AF shortened action potentials and enhanced the constitutive form of IKACh, both key mediators of AF. To establish a causal relationship, we developed a mouse model of Kir3.4 autoimmunity. Electrophysiological study in Kir3.4-immunized mice showed that Kir3.4 autoantibodies significantly reduced atrial effective refractory period and predisposed animals to a 2.8-fold increased susceptibility to AF. CONCLUSIONS: To our knowledge, this is the first report of an autoimmune pathogenesis of AF with direct evidence of Kir3.4 autoantibody-mediated AF.
引用
- Maguy A, Mahendran Y, Tardif JC, et al. Autoimmune Atrial Fibrillation. Circulation. 2023. PMID: 37401487. doi:10.1161/CIRCULATIONAHA.122.062776
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。